Thank you for your thoughtful and thorough answer about your experiences.
Quick follow-up question, I followed up on your Bioinformatics company and seems like (pls correct if I am wrong) your product-line revolves base-calling and resolving genome assemblies from Sanger Sequencing.
How did you guys adapt to the constant changes in sequencing platforms: first generation of sequencers (Sanger) to NGS (Illumina, 454, PacBio)? Especially when a lot of sequencing centers retired a lot of Sanger facilities and staff?
This would require an very long answer, but the short version is we only concentrate on Sanger sequencing. It is an open secret that Sanger sequencing never went away. The large genome centers sold off all their sequencers and they were bought by small facilities and companies around the world. These are all still being used.
Sanger sequencing is far from dead as none of the NGS sequencers are as good at what Sanger sequencing excels at which is sequencing short sections of DNA. This demand is still there.
Quick follow-up question, I followed up on your Bioinformatics company and seems like (pls correct if I am wrong) your product-line revolves base-calling and resolving genome assemblies from Sanger Sequencing.
How did you guys adapt to the constant changes in sequencing platforms: first generation of sequencers (Sanger) to NGS (Illumina, 454, PacBio)? Especially when a lot of sequencing centers retired a lot of Sanger facilities and staff?